EUCTR2007-002133-36-IT进行中（未招募）不适用
A multicenter, randomised, double-blind clinical study to examine the efficacy and safety of ZARZENDA in comparison to Elidel in the management of mild to moderate Atopic Dermatitis in children and adolescents. - ND
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •ICf signed by legal resp and assent oof subject mild to moderate AD (IGA 3 or 4) AD history for at least one year 2-17 years of age at baseline
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Pregnancy, breast feeding Indication for systemic therapy of AD Sinsitivity to Zarzenda or to Butyrospermum Parkii
研究者
相似试验
进行中（未招募）
1 期
A multicenter, randomized, double-blind clinical study to examine the efficacy and safety of Zarzenda® in comparison to Elidel® in the management of mild to moderate atopic dermatitis in children and adolescents.Estudio clínico multicéntrico, aleatorizado y en doble ciego para examinar la eficacia y la seguridad de Zarzenda® en comparación con Elidel® en el tratamiento de la dermatitis atópica leve a moderada en niños y adolescentes.EUCTR2007-002133-36-ESINTENDIS GmbH80
进行中（未招募）
不适用
A multicenter, randomized, double-blind clinical study to examine the efficacy and safety of Zarzenda® in comparison to Elidel® in the management of mild to moderate atopic dermatitis in children and adolescents.EUCTR2007-002133-36-DEINTENDIS GmbH80
招募中
不适用
Clinical trial to evaluate the efficacy and safety of GUGUTAMS capsuleDiseases of The genitoruinary systemKCT0002940Kangdong Sacred Heart Hospital404
进行中（未招募）
1 期
Clinical trial to assess the efficacy and safety of Montelukast in patients with erosive / inflammatory arthrosis of the handsErosive / inflammatory arthrosis of the handsMedDRA version: 20.0Level: LLTClassification code 10003416Term: ArthrosisSystem Organ Class: 100000004859EUCTR2021-001465-20-ESaboratorios Farmalíder S.A.280
进行中（未招募）
不适用
A multi-center, randomized, double-blind clinical trial to evaluate the safety and tolerability of 24 weeks treatment with vildagliptin (50 mg qd) versus placebo in patients with type 2 diabetes and moderate or severe renal insufficiencyEUCTR2007-003723-21-DEovartis Pharma Services AG525